Evelo Biosciences Inc (EVLO)
0.06
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Evelo Biosciences Enterprise Value: 17.82M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
June 14, 2024 | 17.82M |
June 13, 2024 | 17.82M |
June 12, 2024 | 17.82M |
June 11, 2024 | 16.70M |
June 10, 2024 | 16.70M |
June 07, 2024 | 16.70M |
June 06, 2024 | 16.70M |
June 05, 2024 | 16.70M |
June 04, 2024 | 16.70M |
June 03, 2024 | 16.70M |
May 31, 2024 | 16.70M |
May 30, 2024 | 16.70M |
May 29, 2024 | 16.70M |
May 28, 2024 | 16.70M |
May 24, 2024 | 16.70M |
May 23, 2024 | 16.70M |
May 22, 2024 | 16.70M |
May 21, 2024 | 16.70M |
May 20, 2024 | 16.70M |
May 17, 2024 | 17.45M |
May 16, 2024 | 17.61M |
May 15, 2024 | 17.46M |
May 14, 2024 | 17.64M |
May 13, 2024 | 17.44M |
May 10, 2024 | 17.63M |
Date | Value |
---|---|
May 09, 2024 | 17.52M |
May 08, 2024 | 17.52M |
May 07, 2024 | 17.58M |
May 06, 2024 | 17.59M |
May 03, 2024 | 17.51M |
May 02, 2024 | 17.62M |
May 01, 2024 | 17.59M |
April 30, 2024 | 17.62M |
April 29, 2024 | 17.48M |
April 26, 2024 | 17.62M |
April 25, 2024 | 17.55M |
April 24, 2024 | 17.52M |
April 23, 2024 | 17.49M |
April 22, 2024 | 17.51M |
April 19, 2024 | 17.62M |
April 18, 2024 | 17.63M |
April 17, 2024 | 17.52M |
April 16, 2024 | 17.56M |
April 15, 2024 | 17.54M |
April 12, 2024 | 17.64M |
April 11, 2024 | 17.46M |
April 10, 2024 | 17.46M |
April 09, 2024 | 17.54M |
April 08, 2024 | 17.48M |
April 05, 2024 | 17.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.95M
Minimum
Mar 30 2023
917.77M
Maximum
Feb 08 2021
201.74M
Average
146.50M
Median
Nov 03 2020
Enterprise Value Benchmarks
Perspective Therapeutics Inc | 487.28M |
Electromed Inc | 113.97M |
Xtant Medical Holdings Inc | 120.34M |
Asensus Surgical Inc | 81.88M |
Myomo Inc | 86.44M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -12.36M |
Total Expenses (Quarterly) | 10.39M |
EPS Diluted (Quarterly) | -1.42 |
Earnings Yield | -23.33K% |